Genmab Stock News & Updates

[WKN: 565131 | Symbol: GE9]

Hope bearer in oncology: Genmab impresses with Phase 2 data on Petosemtamab

Strong response rates: In combination with standard chemotherapy, Petosemtamab achieves response...

Genmab A/S: Analysts React Positively to the Completion of the Merus Acquisition

Genmab A/S is a pharmaceutical company that operates as a highly specialized innovation hub for antibody...

  • ‹
  • 1
  • ›